ZymoGenetics, Inc. (Nasdaq: ZGEN) today announced that its underwriters fully exercised their overallotment option to purchase an additional 2,100,000 shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE